| 000 | 01817 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514164726.0 | ||
| 264 | 0 | _c20040217 | |
| 008 | 200402s 0 0 eng d | ||
| 022 | _a0091-6749 | ||
| 024 | 7 |
_a10.1016/j.jaci.2003.10.049 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGarrett, Jennifer K | |
| 245 | 0 | 0 |
_aAnti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. _h[electronic resource] |
| 260 |
_bThe Journal of allergy and clinical immunology _cJan 2004 |
||
| 300 |
_a115-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEosinophils _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypereosinophilic Syndrome _xdrug therapy |
| 650 | 0 | 4 |
_aInterleukin-5 _ximmunology |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 700 | 1 | _aJameson, Sean C | |
| 700 | 1 | _aThomson, Blythe | |
| 700 | 1 | _aCollins, Margaret H | |
| 700 | 1 | _aWagoner, Lynne E | |
| 700 | 1 | _aFreese, Debbie K | |
| 700 | 1 | _aBeck, Lisa A | |
| 700 | 1 | _aBoyce, Joshua A | |
| 700 | 1 | _aFilipovich, Alexandra H | |
| 700 | 1 | _aVillanueva, Joyce M | |
| 700 | 1 | _aSutton, Steven A | |
| 700 | 1 | _aAssa'ad, Amal H | |
| 700 | 1 | _aRothenberg, Marc E | |
| 773 | 0 |
_tThe Journal of allergy and clinical immunology _gvol. 113 _gno. 1 _gp. 115-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jaci.2003.10.049 _zAvailable from publisher's website |
| 999 |
_c14429871 _d14429871 |
||